News|Articles|February 16, 2017
Latest Business and People News
Updated employee announcements, business news, awards and recognition in the industry today.
Advertisement
People
SynteractHCR has appointed four new Senior-Level Managers to its International Leadership Team. Miguel Fuentes joins as Executive Director, Service Delivery; Patrick F. Loebs, MSW, MPH, as Senior Regulatory Affairs Manager; Katharina Grote, as Finance Director, and Ewelina Mazur-Janik, MD, as Medical Monitor.
Worldwide Clinical Trials has appointed Margo Holland as its Vice President of Global Quality.
Bracket, a clinical trial technology and specialty services provider, announced the addition of Jennifer Peters to its team as the company's new Senior Vice President and General Manager for the Scientific Services division.
MedAvante, Inc., a provider of technology-based clinical trial services for treatments of central nervous system (CNS) diseases, announced that Susan Vallow, RPh MBA MA, has assumed a new position as Vice President, Patient eSolutions, joining MedAvante from GSK where she was Senior Director and Head of Patient Focused Outcomes.
Greenleaf Health, an FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical and medical device companies, announced that John Jenkins, MD, has joined the firm as Principal, Drug and Biological Products.
INC Research, a global Phase I to IV CRO, announced the appointment of Eric Paul Pâques to the Company’s Board of Directors. Pâques joins the INC Research Board as an Independent Director and will be a Class I Director serving a term ending at the company’s 2018 Annual Meeting.
Almac Diagnostics has announced the appointment of Leeona Galligan, PhD, FRCPath to the position of Vice President, UK Operations.
Business
Business
Chiltern announces the opening of its new process and technology center in Bangalore, India. In total, the company’s offices in India will be able to support more than 600 employees and give Chiltern substantial capacity to advance operations as needed.
endpoint Clinical launches the 500th clinical trial on its proprietary full-service IRT solution, PULSE.
Beaufort, LLC a CRO and consultancy, has obtained ISO 9001:2015 certification. The certification demonstrates that Beaufort provides quality services to the life sciences industry in its clinical research, regulatory affairs, quality and staffing solutions.
Awards
Awards
A 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media.
Recognition
PAREXEL has been named to Training Magazine’s annual “Training Top 125,” honored for developing creative and effective learning and development initiatives for its global workforce.
Worldwide Clinical Trials has been ranked as the industry’s #1 provider of Overall Contract Research, which includes non-clinical research services, in the “2017 Nice Insight Preclinical and Clinical Contract Research Survey.” The survey examines market perceptions of CROs using data collected from key industry executives.
KCR, a German CRO providing clinical development solutions for the pharma, biotech and medical device industries, celebrates its 20-year anniversary of contributing to clinical R&D.
Clintec International, announces the launch of its new brand identity to coincide with their 20th anniversary.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Recent Policy Changes Could Impact Clinical Research
September 10th 2025
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial
2
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
3
eClinical Technology: Misconceptions, Challenges, and Opportunities
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5